HIV/AIDS Clinical Trials

Showing 1781-1800 of 1,802 trials

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

NCT00002375

The purpose of this study is to see if it is safe and effective to treat HIV-infected patients with indinavir (IDV) plus nelfinavir (NFV), 2 anti-HIV medications. It is thought that IDV plus NFV will be a safe drug combination for treating HIV.

HIV Infections

Merck Sharp & Dohme LLC24 participants

Birmingham, Alabama, United States • San Diego, California, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 4

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

NCT00002386

The purpose of this study is to see if indinavir plus two other anti-HIV drugs affect blood clotting in HIV-positive patients with hemophilia.

HIV InfectionsHemophilia A

Merck Sharp & Dohme LLC55 participants

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Atlanta, Georgia, United States +5 more locations

COMPLETEDPhase 2

A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

NCT00002390

The purpose of this study is to see if giving 1592U89 to HIV-infected patients is safe and effective in lowering viral load (level of HIV in the blood) and raising the level of CD4 cells (cells of the body that help fight infection).

HIV Infections

Glaxo Wellcome

Paris, France • Paris, France • Toulouse, France +3 more locations

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients

Related Searches

A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART

The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

A Study of Three Drug Combination Therapies in HIV-Infected Patients Who Have Never Been Treated With Anti-HIV Drugs

A Study of MKC-442 in HIV-Positive Patients

Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment

A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients

The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy

Safety and Effectiveness of PEG-Intron in HIV-Infected Patients

Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs